Dr. Daniel Richardo Carrizosa, MD

  • Charlotte, NC
  • Medical oncologist
NPI1912022716PAC ID6305938952
Medicare services, 2024
615
Medicare patients, 2024
117
Part D claims, 2024
497
Publications
25
Clinical trials
7
Practice address
1000 Blythe Blvd, Charlotte, NC 28203
Practice phone
Call (704) 355-2000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Atrium Health Carolinas Medical Center

Hospital · Charlotte, North Carolina

See all 6 affiliations

Find Dr. Carrizosa's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Daniel Richardo Carrizosa is a medical oncologist in Charlotte, North Carolina

Dr. Carrizosa practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Carrizosa's NPI, 1912022716, was assigned on March 20, 2007. Dr. Carrizosa graduated from University of North Carolina at Chapel Hill School of Medicine in 2004. Dr. Carrizosa holds North Carolina license 200400196.

NPI and contact details
Medicare PAC ID
6305938952
NPI enumeration date
March 20, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(704) 355-2000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
48
Medical school graduation
2004

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Daniel Richardo Carrizosa practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina

Dr. Carrizosa's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Source: Dmand AI Affiliation Data

Dr. Daniel Richardo Carrizosa is affiliated with 5 sites of care and 1 medical group

Dr. Carrizosa's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Carrizosa is also affiliated with Novant Health Presbyterian Medical Center. The medical group on file is Atrium Health Levine Cancer Institute. Dmand AI also links Dr. Carrizosa to 2 more hospitals and 1 group practice or clinic, each named with a free account.

See all 6 affiliations for Dr. Carrizosa

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Daniel Richardo Carrizosa's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carrizosa practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Atrium Health Carolinas Medical CenterAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Carrizosa practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Advocate Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Daniel Richardo Carrizosa is one of 203 medical oncologists in North Carolina

Medical oncology is Dr. Carrizosa's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Carrizosa is licensed in North Carolina.

Specialties and state licenses

  • Medical oncology, North CarolinaPrimaryLicense 200400196 · taxonomy 207RX0202X

Medical oncologists near Dr. Carrizosa

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Daniel Richardo Carrizosa billed Medicare for 615 services in 2024

CMS data shows 615 Medicare services from Dr. Carrizosa across 5 procedure codes in 2024, for 117 Medicare patients. Medicare paid $37,242 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024615
Medicare patients117
Paid by Medicare$37,242
Procedure codes5

Dr. Carrizosa's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 3262024: 3507%
Other services
2023: 312024: 265755%

Dr. Carrizosa compared with the North Carolina median for medical oncologists, 2024

  • Dr. Carrizosa
  • North Carolina median
Medicare services
615vs 52517% above
Medicare patients
117vs 16630% below
Part D claims
251vs 36732% below

Medians across 199 medical oncologists in North Carolina with Dmand AI profiles that report each measure.

Dr. Carrizosa's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Carrizosa

Need commercial claims for Dr. Carrizosa?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Carrizosa and other medical oncologists in North Carolina.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Daniel Richardo Carrizosa treated 117 Medicare patients in 2024, average age 73

CMS counts 117 Medicare patients who saw Dr. Carrizosa in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carrizosa's median patient age at 73, with 47% women.

Medicare patients, 2024117
Average age73
Average risk score2.49
Also on Medicaid11%

Dr. Carrizosa's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Carrizosa's Medicare patients by sex, 2024

  • Women5144%
  • Men6656%

Chronic conditions among Dr. Carrizosa's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol70%
  3. Cancer46%
  4. Arthritis35%
  5. Ischemic heart disease33%
  6. Diabetes31%
  7. Atrial fibrillation28%
  8. COPD28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Carrizosa's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women47%
  • Men53%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Daniel Richardo Carrizosa wrote 497 Medicare Part D claims in 2024

In 2024, Dr. Carrizosa wrote 497 Medicare Part D claims for 75 patients. 77% of them were for generic drugs. CMS names the drug for 251 of them, across 16 drugs with 11 or more claims each, at $738,055 in total drug cost. In 2023, CMS named 248 claims across 17 drugs.

Part D claims, 2024497
Drugs named by CMS16
Total drug cost$738,055
Part D patients75

Dr. Carrizosa's Part D claims by kind of drug, 2024

  • Generic381 claims77%
  • Brand-name and other116 claims23%

Dr. Carrizosa's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Carrizosa's Part D claims, 2024

  • Opioids7%35 of 497 claims
  • Antibiotics4%21 of 497 claims
  • Antipsychotics, patients 65 and over4%20 of 497 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2482024: 2511%

Drugs named by CMS: 16 in 2024, 17 in 2023.

See all prescribing by Dr. Carrizosa

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Daniel Richardo Carrizosa scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Carrizosa for performance year 2024, reported as part of a group. Dr. Carrizosa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carrizosa as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Carrizosa's MIPS scores, performance year 2024

  • 100of 100Final score
  • 99of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Carrizosa by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Daniel Richardo Carrizosa has 25 publications on record

Dmand AI links 25 papers to Dr. Carrizosa, published from 2014 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Lung Neoplasms and Antineoplastic Agents, Hormonal. Dr. Carrizosa has published most often in JCO Oncol Pract. Dr. Carrizosa's most frequent co-authors are Matthew Christopher Ward, MD, Daniel Scott Brickman and Zvonimir Luka Milas, MD.

Papers25
Years published2014 to 2025

Dr. Carrizosa's papers by year, 2015 to 2025

Topics Dr. Carrizosa writes about most

  • Head and Neck Neoplasms
  • Lung Neoplasms
  • Antineoplastic Agents, Hormonal
  • Cytochrome P-450 CYP2D6
  • Genotype
  • Medical Oncology
  • Oropharyngeal Neoplasms
  • Papillomavirus Infections

Dr. Carrizosa's most frequent co-authors

Recent publications by Dr. Carrizosa

See all 25 publications and co-authors

See who Dr. Carrizosa researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Carrizosa works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Daniel Richardo Carrizosa has worked on 7 clinical trials

Dmand AI links Dr. Carrizosa to 7 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Carcinoma, Bronchogenic. National Cancer Institute (NCI) sponsors the most, 4.

Clinical trials with Dr. Carrizosa by phase

  1. NonePhase 1: no trials
  2. 1Phase 1/2: 1 trial
  3. 2Phase 2: 2 trials
  4. 1Phase 2/3: 1 trial
  5. 3Phase 3: 3 trials
  6. NonePhase 4: no trials

Conditions in Dr. Carrizosa's trials

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Carcinoma, Bronchogenic
  • Thoracic Neoplasms
  • Head and Neck Neoplasms

Investigators on the most trials with Dr. Carrizosa

Recent clinical trials with Dr. Carrizosa

See all 7 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Daniel Richardo Carrizosa received $23,655 in industry payments from 2016 to 2025

CMS Open Payments shows 47 general payments to Dr. Carrizosa from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Bristol-Myers Squibb Company paid the most, $8,445. It also lists 5 research payments totaling $1,634 from 2016 to 2019.

General payments to Dr. Carrizosa by program year, 2016 to 2025

General payments to Dr. Carrizosa by kind, 2016 to 2025

$23.7Kin total
  • Consulting fees$11,75250%
  • Speaker and faculty fees$8,49936%
  • Food and beverage$2,1509%
  • Travel and lodging$1,2545%

Companies that paid Dr. Carrizosa the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Carrizosa

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Daniel Richardo Carrizosa graduated from University of North Carolina at Chapel Hill School of Medicine

Dr. Carrizosa graduated from University of North Carolina at Chapel Hill School of Medicine in 2004.

  1. Medical schoolUniversity of North Carolina at Chapel Hill School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Daniel Richardo Carrizosa's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Daniel Richardo Carrizosa

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Daniel Richardo Carrizosa's NPI number?

Dr. Daniel Richardo Carrizosa's NPI number is 1912022716. It was assigned on March 20, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Daniel Richardo Carrizosa?

Dr. Daniel Richardo Carrizosa is a medical oncologist in Charlotte, North Carolina. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Daniel Richardo Carrizosa practice?

Dr. Carrizosa practices at 1000 Blythe Blvd, Charlotte, NC 28203. Dr. Carrizosa's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dmand AI also links Dr. Carrizosa to 2 hospitals and 1 group practice or clinic.

What is Dr. Daniel Richardo Carrizosa's office phone number?

The practice phone on file for Dr. Carrizosa is (704) 355-2000.

What is Dr. Daniel Richardo Carrizosa's medical license number?

Dr. Carrizosa holds North Carolina license 200400196.

Which hospitals is Dr. Daniel Richardo Carrizosa affiliated with?

Dr. Carrizosa practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina. Dr. Carrizosa is also affiliated with Novant Health Presbyterian Medical Center. Dmand AI links Dr. Carrizosa to 2 more hospitals.

What medical group is Dr. Daniel Richardo Carrizosa part of?

Dr. Carrizosa is linked to Atrium Health Levine Cancer Institute.

Does Dr. Daniel Richardo Carrizosa accept Medicare?

Yes. CMS data shows Dr. Carrizosa billed Medicare for 615 services in 2024, and Dr. Carrizosa accepts Medicare assignment.

Does Dr. Daniel Richardo Carrizosa offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Carrizosa as offering telehealth services.

What is Dr. Daniel Richardo Carrizosa's MIPS score?

Dr. Carrizosa's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Daniel Richardo Carrizosa see?

CMS counts 117 Medicare patients who saw Dr. Carrizosa in 2024, with an average age of 73.

What services does Dr. Daniel Richardo Carrizosa bill to Medicare?

In 2024, Dr. Carrizosa's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).

Where did Dr. Daniel Richardo Carrizosa go to medical school?

Dr. Carrizosa graduated from University of North Carolina at Chapel Hill School of Medicine in 2004.

What drugs does Dr. Daniel Richardo Carrizosa prescribe most?

In 2024 Medicare Part D data, Dr. Carrizosa's most prescribed drugs by claims were Levothyroxine Sodium, Olanzapine and Oxycodone HCl.

Has Dr. Daniel Richardo Carrizosa received payments from drug or device companies?

CMS Open Payments shows $23,655 in general payments to Dr. Carrizosa from 14 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Daniel Richardo Carrizosa been practicing?

Dr. Carrizosa graduated from medical school in 2004, 22 years ago.

Does Dr. Daniel Richardo Carrizosa do research?

Dmand AI links 25 publications to Dr. Carrizosa, published from 2014 to 2025. Dr. Carrizosa has worked on 7 clinical trials.

Who does Dr. Daniel Richardo Carrizosa publish with?

Dr. Carrizosa's most frequent co-authors are Matthew Christopher Ward, MD (9 shared papers), Daniel Scott Brickman (8 shared papers) and Zvonimir Luka Milas, MD (8 shared papers).

Selling to medical oncology practices?

See medical oncologists in North Carolina by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)